Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Meclizine

Classification: B

Drug products: Postafen®

ATC code: R06AE05

Summary

Published controlled studies on differences between men and women regarding safety and pharmacokinetics of meclozine/meclizine are lacking.

Additional information

Meclozine in English literature is known as meclizine.

Pharmacokinetics and dosing

No studies with a clinically relevant sex analysis regarding the pharmacokinetics of meclizine have been found.

Effects

No studies with a clinically relevant sex analysis regarding the effects of meclizine have been found.

Adverse effects

No studies with a clinically relevant sex analysis regarding adverse effects of meclizine have been found.

Reproductive health issues

Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan).

Updated: 2022-06-22

Date of litterature search: 2016-12-13

References

  1. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-12-19.] Socialstyrelsens statistikdatabas

Authors: Linnéa Karlsson Lind

Reviewed by: Mia von Euler

Approved by: Karin Schenck-Gustafsson